LU85042A1 - Verfahren zur abbildung des myokard von saeugetieren - Google Patents
Verfahren zur abbildung des myokard von saeugetieren Download PDFInfo
- Publication number
- LU85042A1 LU85042A1 LU85042A LU85042A LU85042A1 LU 85042 A1 LU85042 A1 LU 85042A1 LU 85042 A LU85042 A LU 85042A LU 85042 A LU85042 A LU 85042A LU 85042 A1 LU85042 A1 LU 85042A1
- Authority
- LU
- Luxembourg
- Prior art keywords
- bromide
- halide
- compounds
- quaternary
- injected
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 16
- 238000003384 imaging method Methods 0.000 title claims description 9
- 241000124008 Mammalia Species 0.000 title claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 42
- 150000001768 cations Chemical class 0.000 claims description 16
- 229910052740 iodine Inorganic materials 0.000 claims description 16
- 210000004165 myocardium Anatomy 0.000 claims description 13
- 150000004820 halides Chemical class 0.000 claims description 10
- 229910052794 bromium Inorganic materials 0.000 claims description 9
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 claims description 8
- VUEDNLCYHKSELL-UHFFFAOYSA-N arsonium Chemical group [AsH4+] VUEDNLCYHKSELL-UHFFFAOYSA-N 0.000 claims description 6
- 125000003118 aryl group Chemical group 0.000 claims description 5
- 229910052736 halogen Inorganic materials 0.000 claims description 5
- 150000002367 halogens Chemical class 0.000 claims description 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 5
- 150000003856 quaternary ammonium compounds Chemical class 0.000 claims description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 4
- 229910052757 nitrogen Inorganic materials 0.000 claims description 4
- 150000004023 quaternary phosphonium compounds Chemical class 0.000 claims description 4
- 125000000217 alkyl group Chemical group 0.000 claims description 3
- 229910052785 arsenic Inorganic materials 0.000 claims description 3
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 claims description 3
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 3
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 2
- VQMRBJLNEVCKII-UHFFFAOYSA-M [Br-].C1(=CC=CC=C1)[P+](C1=CC=CC=C1)(C1=CC=CC=C1)C1=CC=CC=C1.[I] Chemical compound [Br-].C1(=CC=CC=C1)[P+](C1=CC=CC=C1)(C1=CC=CC=C1)C1=CC=CC=C1.[I] VQMRBJLNEVCKII-UHFFFAOYSA-M 0.000 claims description 2
- IOEPEYNGWPZHOG-UHFFFAOYSA-M benzyl-(2-bromophenyl)-diphenylphosphanium;bromide Chemical compound [Br-].BrC1=CC=CC=C1[P+](C=1C=CC=CC=1)(C=1C=CC=CC=1)CC1=CC=CC=C1 IOEPEYNGWPZHOG-UHFFFAOYSA-M 0.000 claims description 2
- XBKZMRKXDQBGOQ-UHFFFAOYSA-M benzyl-(2-iodophenyl)-diphenylphosphanium;chloride Chemical compound [Cl-].IC1=CC=CC=C1[P+](C=1C=CC=CC=1)(C=1C=CC=CC=1)CC1=CC=CC=C1 XBKZMRKXDQBGOQ-UHFFFAOYSA-M 0.000 claims description 2
- XKLGFIGRQOUCJC-UHFFFAOYSA-M benzyl-(iodomethyl)-methyl-phenylazanium;bromide Chemical compound [Br-].C=1C=CC=CC=1[N+](CI)(C)CC1=CC=CC=C1 XKLGFIGRQOUCJC-UHFFFAOYSA-M 0.000 claims description 2
- VPARZUQTPKDGJW-UHFFFAOYSA-M iodomethyl(triphenyl)phosphanium;bromide Chemical compound [Br-].C=1C=CC=CC=1[P+](C=1C=CC=CC=1)(CI)C1=CC=CC=C1 VPARZUQTPKDGJW-UHFFFAOYSA-M 0.000 claims description 2
- 229910052698 phosphorus Inorganic materials 0.000 claims description 2
- 239000011574 phosphorus Substances 0.000 claims description 2
- RMKDXABKNACKDU-UHFFFAOYSA-M (2-iodophenyl)-triphenylarsanium;chloride Chemical compound [Cl-].IC1=CC=CC=C1[As+](C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 RMKDXABKNACKDU-UHFFFAOYSA-M 0.000 claims 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims 1
- OFWYYLWAQSLIMC-UHFFFAOYSA-M [Br-].C(C1=CC=CC=C1)[N+](C)(C)CC1=CC=CC=C1.[I] Chemical compound [Br-].C(C1=CC=CC=C1)[N+](C)(C)CC1=CC=CC=C1.[I] OFWYYLWAQSLIMC-UHFFFAOYSA-M 0.000 claims 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 21
- 210000002216 heart Anatomy 0.000 description 18
- 230000002107 myocardial effect Effects 0.000 description 16
- 229910052716 thallium Inorganic materials 0.000 description 15
- BKVIYDNLLOSFOA-UHFFFAOYSA-N thallium Chemical compound [Tl] BKVIYDNLLOSFOA-UHFFFAOYSA-N 0.000 description 15
- 230000002285 radioactive effect Effects 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- 230000000747 cardiac effect Effects 0.000 description 9
- 210000000056 organ Anatomy 0.000 description 9
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 239000011630 iodine Substances 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 6
- -1 quaternary ammonium halides Chemical class 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 5
- 239000012216 imaging agent Substances 0.000 description 5
- 239000012528 membrane Substances 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 150000005840 aryl radicals Chemical class 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000000835 fiber Substances 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- YZCKVEUIGOORGS-NJFSPNSNSA-N Tritium Chemical compound [3H] YZCKVEUIGOORGS-NJFSPNSNSA-N 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 238000010561 standard procedure Methods 0.000 description 3
- 125000001424 substituent group Chemical group 0.000 description 3
- 229910052722 tritium Inorganic materials 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- OIICUUGPVAEJSH-UHFFFAOYSA-M (2-bromophenyl)methyl-ethyl-dimethylazanium;bromide Chemical class [Br-].CC[N+](C)(C)CC1=CC=CC=C1Br OIICUUGPVAEJSH-UHFFFAOYSA-M 0.000 description 2
- LMQMZMZPRQQTFS-UHFFFAOYSA-M (2-iodophenyl)-triphenylphosphanium;bromide Chemical compound [Br-].IC1=CC=CC=C1[P+](C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 LMQMZMZPRQQTFS-UHFFFAOYSA-M 0.000 description 2
- IPJPTPFIJLFWLP-UHFFFAOYSA-M (4-nitrophenyl)methyl-triphenylphosphanium;bromide Chemical compound [Br-].C1=CC([N+](=O)[O-])=CC=C1C[P+](C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 IPJPTPFIJLFWLP-UHFFFAOYSA-M 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 2
- AHFYYJLIKYKOEG-UHFFFAOYSA-N argon;toluene Chemical compound [Ar].CC1=CC=CC=C1 AHFYYJLIKYKOEG-UHFFFAOYSA-N 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- LNIYNESXCOYFPW-UHFFFAOYSA-N dibenzyl(dimethyl)azanium Chemical compound C=1C=CC=CC=1C[N+](C)(C)CC1=CC=CC=C1 LNIYNESXCOYFPW-UHFFFAOYSA-N 0.000 description 2
- 238000011067 equilibration Methods 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 238000005984 hydrogenation reaction Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 230000004807 localization Effects 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 229910052759 nickel Inorganic materials 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 238000000163 radioactive labelling Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- BRKFQVAOMSWFDU-UHFFFAOYSA-M tetraphenylphosphanium;bromide Chemical compound [Br-].C1=CC=CC=C1[P+](C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 BRKFQVAOMSWFDU-UHFFFAOYSA-M 0.000 description 2
- 239000011800 void material Substances 0.000 description 2
- RCJCUXKRMJYUKN-UHFFFAOYSA-M (2-iodophenyl)methyl-triphenylphosphanium;chloride Chemical compound [Cl-].IC1=CC=CC=C1C[P+](C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 RCJCUXKRMJYUKN-UHFFFAOYSA-M 0.000 description 1
- MORAZTHSCBMYRY-UHFFFAOYSA-M (4-iodophenyl)methyl-dimethyl-phenylazanium;bromide Chemical compound [Br-].C=1C=CC=CC=1[N+](C)(C)CC1=CC=C(I)C=C1 MORAZTHSCBMYRY-UHFFFAOYSA-M 0.000 description 1
- FTMNWZHKQGKKAU-UHFFFAOYSA-N 1-(chloromethyl)-2-iodobenzene Chemical compound ClCC1=CC=CC=C1I FTMNWZHKQGKKAU-UHFFFAOYSA-N 0.000 description 1
- YLRBJYMANQKEAW-UHFFFAOYSA-N 1-bromo-4-(bromomethyl)benzene Chemical compound BrCC1=CC=C(Br)C=C1 YLRBJYMANQKEAW-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 101100008041 Arabidopsis thaliana CURT1B gene Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- RSPISYXLHRIGJD-UHFFFAOYSA-N OOOO Chemical compound OOOO RSPISYXLHRIGJD-UHFFFAOYSA-N 0.000 description 1
- JWOLLWQJKQOEOL-UHFFFAOYSA-N OOOOOOOOOOOOO Chemical compound OOOOOOOOOOOOO JWOLLWQJKQOEOL-UHFFFAOYSA-N 0.000 description 1
- 239000007868 Raney catalyst Substances 0.000 description 1
- 229910000564 Raney nickel Inorganic materials 0.000 description 1
- 238000000297 Sandmeyer reaction Methods 0.000 description 1
- QQCKHACFYAWLQY-UHFFFAOYSA-M [Cl-].C1(=CC=CC=C1)[As+](C1=CC=CC=C1)(C1=CC=CC=C1)C1=CC=CC=C1.[I] Chemical compound [Cl-].C1(=CC=CC=C1)[As+](C1=CC=CC=C1)(C1=CC=CC=C1)C1=CC=CC=C1.[I] QQCKHACFYAWLQY-UHFFFAOYSA-M 0.000 description 1
- 230000009056 active transport Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 1
- CLCOXQROCAMRQO-UHFFFAOYSA-M benzyl-dimethyl-phenylazanium;bromide Chemical compound [Br-].C=1C=CC=CC=1[N+](C)(C)CC1=CC=CC=C1 CLCOXQROCAMRQO-UHFFFAOYSA-M 0.000 description 1
- ATJKMVRIUMCSRS-UHFFFAOYSA-M benzyl-dimethyl-phenylphosphanium;bromide Chemical compound [Br-].C=1C=CC=CC=1[P+](C)(C)CC1=CC=CC=C1 ATJKMVRIUMCSRS-UHFFFAOYSA-M 0.000 description 1
- 238000002306 biochemical method Methods 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- VDQQXEISLMTGAB-UHFFFAOYSA-N chloramine T Chemical compound [Na+].CC1=CC=C(S(=O)(=O)[N-]Cl)C=C1 VDQQXEISLMTGAB-UHFFFAOYSA-N 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- IMKFYSIHWZULRD-UHFFFAOYSA-M dibenzyl(dimethyl)azanium;bromide Chemical compound [Br-].C=1C=CC=CC=1C[N+](C)(C)CC1=CC=CC=C1 IMKFYSIHWZULRD-UHFFFAOYSA-M 0.000 description 1
- SMUREOIKBQLUGS-UHFFFAOYSA-M dibenzyl(dimethyl)phosphanium;bromide Chemical compound [Br-].C=1C=CC=CC=1C[P+](C)(C)CC1=CC=CC=C1 SMUREOIKBQLUGS-UHFFFAOYSA-M 0.000 description 1
- HRZGUHKGMYCJJO-UHFFFAOYSA-M dibenzyl-(iodomethyl)-methylazanium;bromide Chemical compound [Br-].C=1C=CC=CC=1C[N+](CI)(C)CC1=CC=CC=C1 HRZGUHKGMYCJJO-UHFFFAOYSA-M 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- DIYXQUIQAXGWIX-UHFFFAOYSA-M dimethyl(diphenyl)azanium;bromide Chemical compound [Br-].C=1C=CC=CC=1[N+](C)(C)C1=CC=CC=C1 DIYXQUIQAXGWIX-UHFFFAOYSA-M 0.000 description 1
- SUJZGMFRCOSTAR-UHFFFAOYSA-M dimethyl(diphenyl)phosphanium;bromide Chemical compound [Br-].C=1C=CC=CC=1[P+](C)(C)C1=CC=CC=C1 SUJZGMFRCOSTAR-UHFFFAOYSA-M 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 230000026045 iodination Effects 0.000 description 1
- 238000006192 iodination reaction Methods 0.000 description 1
- 125000006480 iodobenzyl group Chemical group 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000005567 liquid scintillation counting Methods 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- LSEFCHWGJNHZNT-UHFFFAOYSA-M methyl(triphenyl)phosphanium;bromide Chemical compound [Br-].C=1C=CC=CC=1[P+](C=1C=CC=CC=1)(C)C1=CC=CC=C1 LSEFCHWGJNHZNT-UHFFFAOYSA-M 0.000 description 1
- 210000001700 mitochondrial membrane Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 238000009206 nuclear medicine Methods 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- XYFCBTPGUUZFHI-UHFFFAOYSA-O phosphonium Chemical compound [PH4+] XYFCBTPGUUZFHI-UHFFFAOYSA-O 0.000 description 1
- 150000004714 phosphonium salts Chemical class 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 239000012217 radiopharmaceutical Substances 0.000 description 1
- 229940121896 radiopharmaceutical Drugs 0.000 description 1
- 230000002799 radiopharmaceutical effect Effects 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
- 235000009518 sodium iodide Nutrition 0.000 description 1
- 229940001584 sodium metabisulfite Drugs 0.000 description 1
- 235000010262 sodium metabisulphite Nutrition 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000013223 sprague-dawley female rat Methods 0.000 description 1
- 230000037351 starvation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- KBOPQCLKSDUBAZ-UHFFFAOYSA-M tetrabenzylazanium;bromide Chemical compound [Br-].C=1C=CC=CC=1C[N+](CC=1C=CC=CC=1)(CC=1C=CC=CC=1)CC1=CC=CC=C1 KBOPQCLKSDUBAZ-UHFFFAOYSA-M 0.000 description 1
- KJJIODDNOFLXCL-UHFFFAOYSA-M tetrabenzylphosphanium;bromide Chemical compound [Br-].C=1C=CC=CC=1C[P+](CC=1C=CC=CC=1)(CC=1C=CC=CC=1)CC1=CC=CC=C1 KJJIODDNOFLXCL-UHFFFAOYSA-M 0.000 description 1
- IUVXCVGGLRYGFE-UHFFFAOYSA-N tetraphenyl-lambda5-arsane hydrochloride Chemical compound C1=CC=C(C=C1)[AsH](C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4.Cl IUVXCVGGLRYGFE-UHFFFAOYSA-N 0.000 description 1
- NZUQEBQRKNZZDO-UHFFFAOYSA-M tetraphenylarsanium;bromide Chemical compound [Br-].C1=CC=CC=C1[As+](C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 NZUQEBQRKNZZDO-UHFFFAOYSA-M 0.000 description 1
- VJFXTJZJJIZRKP-UHFFFAOYSA-M tetraphenylazanium;bromide Chemical compound [Br-].C1=CC=CC=C1[N+](C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 VJFXTJZJJIZRKP-UHFFFAOYSA-M 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 229960001479 tosylchloramide sodium Drugs 0.000 description 1
- RIOQSEWOXXDEQQ-UHFFFAOYSA-O triphenylphosphanium Chemical compound C1=CC=CC=C1[PH+](C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-O 0.000 description 1
- XREXPQGDOPQPAH-QKUPJAQQSA-K trisodium;[(z)-18-[1,3-bis[[(z)-12-sulfonatooxyoctadec-9-enoyl]oxy]propan-2-yloxy]-18-oxooctadec-9-en-7-yl] sulfate Chemical compound [Na+].[Na+].[Na+].CCCCCCC(OS([O-])(=O)=O)C\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CC(CCCCCC)OS([O-])(=O)=O)COC(=O)CCCCCCC\C=C/CC(CCCCCC)OS([O-])(=O)=O XREXPQGDOPQPAH-QKUPJAQQSA-K 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Optics & Photonics (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/433,871 US4446123A (en) | 1982-10-13 | 1982-10-13 | Process of radioimaging the myocardium of mammals utilizing radiolabeled lipophilic cations |
| US43387182 | 1982-10-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LU85042A1 true LU85042A1 (de) | 1984-04-02 |
Family
ID=23721862
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LU85042A LU85042A1 (de) | 1982-10-13 | 1983-10-12 | Verfahren zur abbildung des myokard von saeugetieren |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US4446123A (enExample) |
| JP (1) | JPS59139326A (enExample) |
| BE (1) | BE897968A (enExample) |
| CA (1) | CA1219207A (enExample) |
| DE (1) | DE3336748A1 (enExample) |
| FR (1) | FR2534576B1 (enExample) |
| GB (1) | GB2128191B (enExample) |
| IT (1) | IT1205396B (enExample) |
| LU (1) | LU85042A1 (enExample) |
| NL (1) | NL8303481A (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2001271248A1 (en) * | 2000-04-28 | 2001-11-12 | Duke University | 18f-labeled choline analogs |
| US6548042B2 (en) * | 2000-08-07 | 2003-04-15 | Arstad Erik | Bis-phosphonate compounds |
| TWI266634B (en) * | 2002-02-06 | 2006-11-21 | Univ Johns Hopkins | Non-invasive diagnostic imaging technology for mitochondria dysfunction using radiolabeled lipophilic salts |
| AU2011203177B2 (en) * | 2004-02-24 | 2012-04-26 | The General Hospital Corporation | Catalytic radiofluorination |
| US9017724B2 (en) * | 2004-02-24 | 2015-04-28 | The General Hospital Corporation | Catalytic radiofluorination |
| US8257680B1 (en) | 2004-02-24 | 2012-09-04 | The General Hospital Corporation | Catalytic radiofluorination |
| EP2388017B1 (en) * | 2004-02-24 | 2014-12-24 | The General Hospital Corporation | Catalytic radiofluorination |
| US8388936B2 (en) * | 2008-02-22 | 2013-03-05 | Mcw Research Foundation, Inc. | In vivo mitochondrial labeling using positively-charged nitroxide enhanced and gadolinium chelate enhanced magnetic resonance imaging |
| MX375108B (es) | 2008-03-21 | 2025-03-06 | Massachusetts Gen Hospital | Compuestos y composiciones para la deteccion y el tratamiento de la enfermedad de alzheimer y trastornos relacionados. |
| US9205156B2 (en) * | 2010-05-27 | 2015-12-08 | Hadasit Medical Research Services & Development Limited | Molecular imaging agents |
| JP6285164B2 (ja) * | 2013-12-05 | 2018-02-28 | デクセリアルズ株式会社 | 化合物、熱硬化性樹脂組成物、及び熱硬化性シート |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4107283A (en) * | 1976-07-19 | 1978-08-15 | New England Nuclear Corporation | Tracer for circulation determinations |
| JPS5572640A (en) * | 1978-11-27 | 1980-05-31 | Automob Antipollut & Saf Res Center | Air-fuel ratio control device |
| DE2965469D1 (en) * | 1978-11-29 | 1983-07-07 | Hoffmann La Roche | Radioiodine containing amines, their preparation and their use as brain imaging agents |
| US4360511A (en) * | 1978-11-29 | 1982-11-23 | Medi-Physics, Inc. | Amines useful as brain imaging agents |
| NL7900964A (nl) * | 1979-02-07 | 1980-08-11 | Byk Mallinckrodt Cil Bv | Nieuwe radioactief gemerkte aminen, werkwijze ter bereiding van de nieuwe verbindingen, alsmede diagnostische preparaten op basis van de nieuwe verbindingen. |
| US4387087A (en) * | 1980-04-18 | 1983-06-07 | Research Corporation | Cationic lipophilic complexes of 99m Tc and their use for myocardial and hepatobiliary imaging |
-
1982
- 1982-10-13 US US06/433,871 patent/US4446123A/en not_active Expired - Fee Related
-
1983
- 1983-10-08 DE DE19833336748 patent/DE3336748A1/de not_active Withdrawn
- 1983-10-10 NL NL8303481A patent/NL8303481A/nl not_active Application Discontinuation
- 1983-10-12 LU LU85042A patent/LU85042A1/de unknown
- 1983-10-12 JP JP58189395A patent/JPS59139326A/ja active Granted
- 1983-10-12 BE BE2/60226A patent/BE897968A/nl not_active IP Right Cessation
- 1983-10-12 GB GB08327249A patent/GB2128191B/en not_active Expired
- 1983-10-12 IT IT68048/83A patent/IT1205396B/it active
- 1983-10-13 CA CA000438933A patent/CA1219207A/en not_active Expired
- 1983-10-13 FR FR8316263A patent/FR2534576B1/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| IT1205396B (it) | 1989-03-15 |
| GB2128191B (en) | 1986-05-08 |
| FR2534576A1 (fr) | 1984-04-20 |
| BE897968A (nl) | 1984-01-30 |
| JPS6217974B2 (enExample) | 1987-04-21 |
| GB2128191A (en) | 1984-04-26 |
| IT8368048A0 (it) | 1983-10-12 |
| CA1219207A (en) | 1987-03-17 |
| US4446123A (en) | 1984-05-01 |
| DE3336748A1 (de) | 1984-07-05 |
| FR2534576B1 (fr) | 1986-09-19 |
| GB8327249D0 (en) | 1983-11-16 |
| JPS59139326A (ja) | 1984-08-10 |
| NL8303481A (nl) | 1984-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69633461T2 (de) | Dopamin und serotonin transport-ligande und bilderzeugungsmitteln | |
| JPH03115231A (ja) | ↑９↑９↑ｍＴｃの陽イオン性親脂性錯体を製造するためのキット | |
| DE112018003015B4 (de) | 99mTc-MARKIERTES ISONITRIL-ENTHALTENDES GLUCOSEDERIVAT UND HERSTELLUNGSVERFAHREN UND VERWENDUNG DAVON | |
| DE69320481T2 (de) | Tetraazamakrocyclische metallkomplexe | |
| LU85042A1 (de) | Verfahren zur abbildung des myokard von saeugetieren | |
| US4795626A (en) | 99m Tc.sup.(III) myocardial imaging agents which are non-reducable in vivo | |
| DE3032781A1 (de) | Verfahren zur selektiven ablagerung einer radiopharmazeutischen verbindung in einem zielgewebe oder -organ und verbindungen zur durchfuehrung des verfahrens | |
| DE69109235T2 (de) | Verfahren zur Herstellung einer radiopharmazeutischer Zubereitung. | |
| DE4311023C2 (de) | Bifunktionelle chalkogenatom-unterbrochene Chelatbildner von Typ XN¶1¶S¶1¶O¶1¶ für radioaktive Isotope, deren Metallkomplexe, Verfahren zu ihrer Herstellung sowie diese enthaltende pharmazeutische Mittel | |
| DE68925594T2 (de) | Liganden und ihre Komplexe mit Technetium-99m | |
| DE2947500C2 (de) | Radiojodierte ω -Phenylfettsäuren, ihre Herstellung und deren Verwendung zur szintigraphischen Untersuchung des Herzmuskels und der Leber | |
| DE102012208375B4 (de) | Satz und Verfahren zur Herstellung eines Radiopharmakons | |
| DE69231811T2 (de) | Uebergangsmetall-Nitridokomplex enthaltendes Radiopharmazeutisches Produkt mit einer Neigung zum Gehirn, Verfahren zu deren Herstellung | |
| DE69723242T2 (de) | Ternäre radiopharmazeutische komplexe | |
| WO1997010853A2 (de) | Bifunktionelle nicotinamid-chelatbildner vom typ n2s2 für radioaktive isotope | |
| DE60014375T2 (de) | Uebergangsmetallkomplexe der vii-nebengruppe mit multidentaten aminopolycarboxylat-liganden und ein kit zu deren herstellung | |
| DE3852828T2 (de) | Tris(isonitrile)kupfer(i)-addukte zur herstellung von radionuklid-komplexen. | |
| DE2551480B2 (de) | Technetium-99m-markiertes Nierendiagnostikum und Verfahren zu seiner Herstellung | |
| DE69117741T2 (de) | Neue vorangeordnete sechszähnige liganden verwendbar in röntgenologischen bildformenden wirkstoffen | |
| DE2239791A1 (de) | Verfahren zur herstellung von mit indium-113m markiertem humantransferrin | |
| DE2419310C3 (de) | Verwendung von Tc-99m-Komplexen | |
| EP0201005A2 (en) | 99mTc(III)myocardial imaging agents which are non-reducable in vivo | |
| Huang et al. | In vivo stability and distribution of [131I] iodomethyl trimethylammonium chloride: Concise communication | |
| DE69620762T2 (de) | Cardiotropische radiopharmazeutika,die einen übergangsmetall-nitrid-komplex enthalten und die eine rasche myocardial-eliminierung aufweisen | |
| EP2849805B1 (de) | Satz und verfahren zur herstellung eines radiopharmakons |